🔗 Permalink

Inventor profile of:

Mark Jon Olsen

City:

Phoenix, Arizona

Country:

United States

Published Applications:

Last publication date:

2022-08-11

Top Assignees for applications by Mark Jon Olsen

The entities that hold a legal rights for patent applications filed by inventor Olsen Mark Jon:

MIDWESTERN UNIVERSITY 9 DOWNERS GROVE, IL United States
RHODE ISLAND HOSPITAL 2 Providence, RI United States

Recent patent applications by Olsen Mark Jon

Mark Jon Olsen from Phoenix, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-08-11

US20220251076A1

Chemistry; metallurgy

Inhibitors of Beta-Hydoxylase for Treatment of Cancer

#2 | 2021-04-01

US20210094927A1

Chemistry; metallurgy

Isotopically-stabilized tetronimide compounds

#3 | 2021-02-04

US20210032233A1

Chemistry; metallurgy

Inhibitors of Beta-Hydroxylase for Treatment of Cancer

#4 | 2021-01-14

US20210009713A1

Chemistry; metallurgy

Methods of using monoclonal antibodies targeting epitopes of ASPH

#5 | 2020-08-20

US20200262804A1

Chemistry; metallurgy

Isotopically-stabilized tetronimide compounds

#6 | 2019-12-19

US20190382506A1

Chemistry; metallurgy

Monoclonal antibodies targeting epitopes of ASPH

#7 | 2019-10-03

US20190300519A1

Chemistry; metallurgy

Inhibitors of beta-hydroxylase for treatment of cancer

#8 | 2019-01-03

US20190002453A1

Chemistry; metallurgy

Inhibitors of β-hydroxylase for treatment of cancer

#9 | 2018-08-23

US20180237427A1

Chemistry; metallurgy

Inhibitors of β-hydroxylase for treatment of cancer

#10 | 2018-01-11

US20180009798A1

Chemistry; metallurgy

Inhibitors of beta-hydroxylase for treatment of cancer

#11 | 2015-07-30

US20150210677A1

Chemistry; metallurgy

Inhibitors of beta-hydroxylase for treatment of cancer

InventorID:

1239481 ⎘